BIOTRONICS 3D LIMITED

Their core work

Biotronics 3D is a London-based SME specializing in medical imaging software and AI-driven clinical decision support. They develop platforms that process and analyze medical images — from coronary artery simulations to prostate cancer diagnostics — enabling clinicians to make better-informed treatment decisions. Their technical strength lies in building cloud infrastructure for medical image repositories and applying machine learning (including federated learning) to sensitive healthcare data.

What they specialise in

How they've shifted over time

In their early H2020 participation (2015–2019), Biotronics 3D worked across diverse health challenges — Parkinson's disease management, coronary artery simulation, and drug allergy diagnostics — functioning as a versatile medical software contributor. From 2018 onward, their focus sharpened significantly toward AI-powered medical imaging, culminating in ProCAncer-I, their largest project by far, which integrates advanced AI techniques with large-scale image repositories on cloud infrastructure. The trajectory shows a clear move from general health IT toward becoming a specialist in AI-driven medical image analysis platforms.

Biotronics 3D is converging on AI-powered medical imaging infrastructure, making them a strong fit for future projects involving clinical image analysis, radiology AI, or cancer diagnostics platforms.

How they like to work

Biotronics 3D always participates as a partner rather than a coordinator, suggesting they bring specialized technical capability to larger consortium efforts rather than driving project governance. With 61 unique partners across 20 countries from just 5 projects, they operate in large, internationally diverse consortia — their average consortium size is substantial. This makes them a reliable, low-friction technical partner who integrates well into complex multi-country teams.

With 61 unique consortium partners across 20 countries, Biotronics 3D has built a broad European network despite being a small company. Their reach spans most of Europe, reflecting the large health and digital consortia they participate in.

What sets them apart

Biotronics 3D sits at a relatively rare intersection: they are a small company with deep expertise in both medical imaging software and AI/ML infrastructure for healthcare. Unlike academic groups who research these topics, B3D builds deployable platforms — cloud repositories, annotation tools, and clinical decision support interfaces. Their experience with federated learning (MUSKETEER) adds a privacy-preserving dimension that is increasingly critical for any project handling medical images across borders.

Highlights from their portfolio

• ProCAncer-I
  Their largest project (EUR 605K) and most recent, building an EU-wide AI platform for prostate cancer imaging — represents their current strategic direction.
• MUSKETEER
  Focused on federated privacy-preserving machine learning, a capability directly transferable to secure medical data sharing across institutions.
• SMARTool
  Clinical decision support for coronary artery disease using simulation modeling — demonstrates their ability to turn complex imaging data into actionable clinical tools.